BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 17917969)

  • 21. Gene expression profile of vascular endothelial growth factor (VEGF) and its receptors in various cell types of the canine lymph node using laser capture microdissection (LCM).
    Jais A; Klein D; Wolfesberger B; Walter I
    Vet Immunol Immunopathol; 2011 Apr; 140(3-4):207-14. PubMed ID: 21211854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of vascular endothelial growth factors VEGF- C and D, VEGFR-3, and comparison of lymphatic vessels density labeled with D2-40 antibodies as a prognostic factors in vulvar intraepithelial neoplasia (VIN) and invasive vulvar cancer.
    Jach R; Dyduch G; Radon-Pokracka M; Przybylska P; Mika M; Dulinska-Litewka J; Zajac K; Huras H; Streb J; Stangel-Wojcikiewicz K; Dziadek O; Galarowicz B
    Neuro Endocrinol Lett; 2011; 32(4):530-9. PubMed ID: 21876509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of vascular endothelial growth factor receptor-3 by lymphatic endothelial cells is associated with lymph node metastasis in prostate cancer.
    Zeng Y; Opeskin K; Baldwin ME; Horvath LG; Achen MG; Stacker SA; Sutherland RL; Williams ED
    Clin Cancer Res; 2004 Aug; 10(15):5137-44. PubMed ID: 15297417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential in vivo and in vitro expression of vascular endothelial growth factor (VEGF)-C and VEGF-D in tumors and its relationship to lymphatic metastasis in immunocompetent rats.
    Krishnan J; Kirkin V; Steffen A; Hegen M; Weih D; Tomarev S; Wilting J; Sleeman JP
    Cancer Res; 2003 Feb; 63(3):713-22. PubMed ID: 12566318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer.
    Von Marschall Z; Scholz A; Stacker SA; Achen MG; Jackson DG; Alves F; Schirner M; Haberey M; Thierauch KH; Wiedenmann B; Rosewicz S
    Int J Oncol; 2005 Sep; 27(3):669-79. PubMed ID: 16077915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymphangiogenesis and its relationship with lymphatic metastasis and prognosis in malignant melanoma.
    Liu B; Ma J; Wang X; Su F; Li X; Yang S; Ma W; Zhang Y
    Anat Rec (Hoboken); 2008 Oct; 291(10):1227-35. PubMed ID: 18561194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular endothelial growth factor-D expression in human atherosclerotic lesions.
    Rutanen J; Leppänen P; Tuomisto TT; Rissanen TT; Hiltunen MO; Vajanto I; Niemi M; Häkkinen T; Karkola K; Stacker SA; Achen MG; Alitalo K; Ylä-Herttuala S
    Cardiovasc Res; 2003 Oct; 59(4):971-9. PubMed ID: 14553837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. VEGFR-3, VEGF-C and VEGF-D mRNA quantification by RT-PCR in different human cell types.
    Leclers D; Durand K; Cook-Moreau J; Rabinovitch-Chable H; Sturtz FG; Rigaud M
    Anticancer Res; 2006; 26(3A):1885-91. PubMed ID: 16827121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascular endothelial growth factor-C (VEGF-C) promotes angiogenesis by induction of COX-2 in leukemic cells via the VEGF-R3/JNK/AP-1 pathway.
    Chien MH; Ku CC; Johansson G; Chen MW; Hsiao M; Su JL; Inoue H; Hua KT; Wei LH; Kuo ML
    Carcinogenesis; 2009 Dec; 30(12):2005-13. PubMed ID: 19825968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vascular endothelial growth factor-D activates VEGFR-3 expressed in osteoblasts inducing their differentiation.
    Orlandini M; Spreafico A; Bardelli M; Rocchigiani M; Salameh A; Nucciotti S; Capperucci C; Frediani B; Oliviero S
    J Biol Chem; 2006 Jun; 281(26):17961-7. PubMed ID: 16624815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-VEGF-A therapy reduces lymphatic vessel density and expression of VEGFR-3 in an orthotopic breast tumor model.
    Whitehurst B; Flister MJ; Bagaitkar J; Volk L; Bivens CM; Pickett B; Castro-Rivera E; Brekken RA; Gerard RD; Ran S
    Int J Cancer; 2007 Nov; 121(10):2181-91. PubMed ID: 17597103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Malignant hematopoietic cells induce an increased expression of VEGFR-1 and VEGFR-3 on bone marrow endothelial cells via AKT and mTOR signalling pathways.
    Mirshahi P; Toprak SK; Faussat AM; Dubrulle S; Marie JP; Soria C; Soria J; Mirshahi M
    Biochem Biophys Res Commun; 2006 Oct; 349(3):1003-10. PubMed ID: 16959214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of vascular endothelial growth factor (VEGF)-C and -D in gastric carcinoma.
    Shida A; Fujioka S; Kobayashi K; Ishibashi Y; Nimura H; Mitsumori N; Yanaga K
    Int J Clin Oncol; 2006 Feb; 11(1):38-43. PubMed ID: 16508727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of vascular endothelial growth factor in lymphomas and Castleman's disease.
    Foss HD; Araujo I; Demel G; Klotzbach H; Hummel M; Stein H
    J Pathol; 1997 Sep; 183(1):44-50. PubMed ID: 9370946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vascular endothelial growth factor receptor 3 is involved in tumor angiogenesis and growth.
    Laakkonen P; Waltari M; Holopainen T; Takahashi T; Pytowski B; Steiner P; Hicklin D; Persaud K; Tonra JR; Witte L; Alitalo K
    Cancer Res; 2007 Jan; 67(2):593-9. PubMed ID: 17234768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppression of lymphangiogenesis in human lymphatic endothelial cells by simultaneously blocking VEGF-C and VEGF-D/VEGFR-3 with norcantharidin.
    Liu ZY; Qiu HO; Yuan XJ; Ni YY; Sun JJ; Jing W; Fan YZ
    Int J Oncol; 2012 Nov; 41(5):1762-72. PubMed ID: 22922710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential expression of vascular endothelial growth factor isoforms and receptor subtypes in the infarcted heart.
    Zhao T; Zhao W; Chen Y; Liu L; Ahokas RA; Sun Y
    Int J Cardiol; 2013 Sep; 167(6):2638-45. PubMed ID: 22818386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascular endothelial growth factors signalling in normal human dental pulp: a study of gene and protein expression.
    Virtej A; Løes S; Iden O; Bletsa A; Berggreen E
    Eur J Oral Sci; 2013 Apr; 121(2):92-100. PubMed ID: 23489898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymphangiogenesis in aortic valve stenosis--novel regulatory roles for valvular myofibroblasts and mast cells.
    Syväranta S; Helske S; Lappalainen J; Kupari M; Kovanen PT
    Atherosclerosis; 2012 Apr; 221(2):366-74. PubMed ID: 22281299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression and predictive value of lymph-specific markers in urothelial carcinoma of the bladder.
    von Hardenberg J; Martini T; Knauer A; Ströbel P; Becker A; Herrmann E; Schubert C; Steidler A; Bolenz C
    Urol Oncol; 2014 Jan; 32(1):54.e9-17. PubMed ID: 24360666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.